SecBot SecBot
8-K ·Filed Nov 3, 2026

HSIC

HENRY SCHEIN INC
BULLISH
Impact 6/10
Horizonweeks Processed13d 14h ago SEC0001000228-26-000059
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The raised FY2026 EPS guidance implies Q4 non-GAAP EPS of approximately $1.36-$1.42, suggesting continued momentum. Watch for further margin expansion from value creation initiatives and whether U.S. dental merchandise growth sustains above 8%.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$82.50
T+0 close · Nov 3, 2026 · via day close
Latest settled
+7.56%
T+5 · $88.74 · next T+20 in 15d
Vs SPY
+8.15%
α at T+5
Latest observation
+5.56%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $82.50entry
  2. T+1 · 13d ago +6.96%α +5.31% · $88.24
  3. T+5 · 7d ago +7.56%α +8.15% · $88.74
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Henry Schein reported Q3 2026 non-GAAP diluted EPS of $1.56, beating the $1.36 consensus by 14.7%, on revenue of $3.471B (in line with the $3.48B estimate). The company raised its FY2026 non-GAAP EPS guidance to $5.50-$5.56 (from $5.29-$5.39) and its Adjusted EBITDA growth outlook to high-single-digits. U.S. dental merchandise sales grew 8.6% driven by market share gains, while total revenue grew 4.0% YoY.

Key Financial Metrics

EPS (Adj.)
$1.56
est $1.36 · +14.7% · GAAP: $1.06
Revenue
$3.5B
est $3.5B · -0.3% · +4.0% YoY
Rating
beat
Guidance
4.5% to 5.5% sales growth
raised
Free Cash Flow
$116.0M
Gross Margin
31.83%

Key Facts

  • Q3 2026 non-GAAP diluted EPS of $1.56 vs consensus of $1.36 (beat by 14.7%)
  • Q3 2026 GAAP diluted EPS of $1.06, up 26.2% YoY from $0.84
  • Q3 2026 revenue of $3.471B, up 4.0% YoY (3.1% internal growth)
  • FY2026 non-GAAP EPS guidance raised to $5.50-$5.56 from $5.29-$5.39
  • FY2026 Adjusted EBITDA growth guidance raised to high-single-digits from mid-to-high single-digits
  • U.S. dental merchandise sales grew 8.6% YoY, driven by volume and market share gains
  • Adjusted EBITDA margin expanded 40 bps to 9.24%
  • Company repurchased $125M in shares during Q3, $450M YTD
  • Non-GAAP diluted EPS excluding tariff refunds and remeasurement gains was $1.37, up 19.1% YoY

Financial Impact

EPS beat of $0.20 (14.7%) on consensus of $1.36; guidance raised by $0.17-$0.21 at midpoint

epsrevenueguidanceadjusted_ebitda

Segment Breakdown

SegmentRevenueGrowth
Global Distribution and Value-Added Services$2.9B+3.7%
Global Specialty Products$391.0M+6.1%
Global Technology$181.0M+5.2%

Risk Factors

  • Tariff refunds contributed $0.19 to Q3 EPS; future quarters assume no significant refunds
  • Global Medical Distribution sales growth slowed to 1.1%
  • Global Value-Added Services sales declined 4.8% YoY
  • Restructuring costs of $22M in Q3 and ongoing value creation consulting costs

Market Snapshot

Exchange
Nasdaq
Sector
Wholesale-Medical, Dental & Hospital Equipment & Supplies
Analyst Consensus
58% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001000228-26-000059
Document: hsic-20261103.htm0001000228-26-000059
Document: 0001000228-26-000059-index-headers.html0001000228-26-000059
Document: 0001000228-26-000059-index.html0001000228-26-000059
Document: 0001000228-26-000059.txt0001000228-26-000059
8-K Data (Synthetic)0001000228-26-000059

Track record

24 reports on HSIC

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +10.65% at T+20 after the Mar 2, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today 8-K Neutral 2/10 Entry price pending
  2. Nov 12, 20264d ago SC 13G/A Bearish 4/10 Entry $86.14 Now $84.96 +1.37% settles Nov 19
  3. Nov 6, 202610d ago 3 Neutral 1/10 Entry $88.41 to $84.96 Now $84.96 −3.90% ▼ −3.90% −2.21% vs SPY
  4. Nov 3, 202613d ago 8-K Bullish 6/10 Viewing Entry $82.50 to $88.74 Now $84.96 +2.98% ▲ +7.56% +8.15% vs SPY
  5. Oct 8, 20265w ago 8-K Neutral 3/10 Entry $84.63 to $86.99 Now $84.96 +0.39% ▲ +2.79% +3.07% vs SPY
  6. Sep 22, 20267w ago 8-K Neutral 3/10 Entry $87.43 to $84.97 Now $84.96 −2.83% ▼ −2.81% −1.63% vs SPY
  7. Aug 4, 202614w ago 8-K Bullish 6/10 Entry $89.11 to $89.18 Now $84.96 −4.66% ▲ +0.08% +0.18% vs SPY
  8. Aug 4, 202614w ago Institutional Cluster Mixed 4/10 Entry $89.11 to $89.18 Now $84.96 −4.66% ▲ +0.08% +0.18% vs SPY
  9. Jul 30, 202615w ago 8-K Neutral 3/10 Entry $85.17 to $88.23 Now $84.96 −0.25% ▲ +3.59% −0.03% vs SPY
  10. Jun 11, 202622w ago Institutional Cluster Mixed 5/10 Entry $81.25 to $79.92 Now $84.96 +4.57% ▼ −1.64% −2.31% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens Wed (11h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026